目的分析子宫输卵管造影时出现造影剂逆流的原因探析及处理对策。方法随机选取该院子宫输卵管造影检查患者100例,收治时间在2015年2月—2016年7月期间,按照其是否发生造影剂逆流情况分为逆流组、无逆流组,每组患者50例,然后对其逆流情...目的分析子宫输卵管造影时出现造影剂逆流的原因探析及处理对策。方法随机选取该院子宫输卵管造影检查患者100例,收治时间在2015年2月—2016年7月期间,按照其是否发生造影剂逆流情况分为逆流组、无逆流组,每组患者50例,然后对其逆流情况进行分析,实施相应的处理对策。结果无逆流组造影时间在月经后3~4 d 40例、在月经后5~7 d患者10例,月经持续时间为3~5 d 28例、4~10 d 22例,输卵管畅通35例、不畅通15例,子宫形态正常20例、畸形30例,原发性不孕20例、继发性不孕30例,两组相比差异有统计学意义(P<0.05)。结论子宫输卵管造影时出现造影剂逆流的原因与多种因素密切相关,为了预防造影剂逆流情况发生,应实施针对性处理对策,避免严重后果发生。展开更多
AIM To evaluate the risk profile of sulfur hexafluoride in voiding urosonography(VUS) based on a large cohort of children.METHODS Since 2011 sulfur hexafluoride(SH,SonoV ue?,Bracco,Italy) is the only ultrasound contra...AIM To evaluate the risk profile of sulfur hexafluoride in voiding urosonography(VUS) based on a large cohort of children.METHODS Since 2011 sulfur hexafluoride(SH,SonoV ue?,Bracco,Italy) is the only ultrasound contrast available in the European Union and its use in children has not been approved.Within a 4-year-period,531 children with suspected or proven vesicoureteral reflux(f/m = 478/53; mean age 4.9 years; 1 mo-25.2 years) following parental informed consent underwent VUS with administration of 2.6 ± 1.2 mL SH in a two-center study.A standardizedtelephone survey on adverse events was conducted three days later.RESULTS No acute adverse reactions were observed.The survey revealed subacute,mostly self-limited adverse events in 4.1%(22/531).The majority of observed adverse events(17/22) was not suspected to be caused by an allergic reaction: Five were related to catheter placement,three to reactivated urinary tract infections,five were associated with perineal disinfection before voiding urosonography or perineal dermatitis and four with a common cold.In five patients(0.9%) hints to a potential allergic cause were noted: Perineal urticaria was reported in three interviews and isolated,mild fever in two.These were minor self-limited adverse events with a subacute onset and no hospital admittance was necessary.Ninety-six point two percent of the parents would prefer future VUS examinations with use of SH.CONCLUSION No severe adverse events were observed and indications of self-limited minor allergic reactions related to intravesical administration of SH were reported in less than 1%.展开更多
文摘目的分析子宫输卵管造影时出现造影剂逆流的原因探析及处理对策。方法随机选取该院子宫输卵管造影检查患者100例,收治时间在2015年2月—2016年7月期间,按照其是否发生造影剂逆流情况分为逆流组、无逆流组,每组患者50例,然后对其逆流情况进行分析,实施相应的处理对策。结果无逆流组造影时间在月经后3~4 d 40例、在月经后5~7 d患者10例,月经持续时间为3~5 d 28例、4~10 d 22例,输卵管畅通35例、不畅通15例,子宫形态正常20例、畸形30例,原发性不孕20例、继发性不孕30例,两组相比差异有统计学意义(P<0.05)。结论子宫输卵管造影时出现造影剂逆流的原因与多种因素密切相关,为了预防造影剂逆流情况发生,应实施针对性处理对策,避免严重后果发生。
文摘AIM To evaluate the risk profile of sulfur hexafluoride in voiding urosonography(VUS) based on a large cohort of children.METHODS Since 2011 sulfur hexafluoride(SH,SonoV ue?,Bracco,Italy) is the only ultrasound contrast available in the European Union and its use in children has not been approved.Within a 4-year-period,531 children with suspected or proven vesicoureteral reflux(f/m = 478/53; mean age 4.9 years; 1 mo-25.2 years) following parental informed consent underwent VUS with administration of 2.6 ± 1.2 mL SH in a two-center study.A standardizedtelephone survey on adverse events was conducted three days later.RESULTS No acute adverse reactions were observed.The survey revealed subacute,mostly self-limited adverse events in 4.1%(22/531).The majority of observed adverse events(17/22) was not suspected to be caused by an allergic reaction: Five were related to catheter placement,three to reactivated urinary tract infections,five were associated with perineal disinfection before voiding urosonography or perineal dermatitis and four with a common cold.In five patients(0.9%) hints to a potential allergic cause were noted: Perineal urticaria was reported in three interviews and isolated,mild fever in two.These were minor self-limited adverse events with a subacute onset and no hospital admittance was necessary.Ninety-six point two percent of the parents would prefer future VUS examinations with use of SH.CONCLUSION No severe adverse events were observed and indications of self-limited minor allergic reactions related to intravesical administration of SH were reported in less than 1%.
